HIGHLIGHTS
- who: Antonio Giovanni Solimando from the United States Department of Biomedical Sciences and Human Oncology, School of Medicine, u2018Aldo Moro` University have published the Article: Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche, in the Journal: (JOURNAL)
- what: The finding that MCL-1, an inhibitor of apoptosis, and BCL-2 levels are modulated by the tumorassociated microenvironment has stimulated further investigation focused on MCL-1 inhibition.
SUMMARY
Recent advances in the treatment of MM include the use of novel therapeutic strategies, such as immunomodulatory drugs (thalidomide . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.